Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock Information | RedChip

Regulus Therapeutics Inc. (NASDAQ: RGLS) Listen to this Section


$1.60
+0.0100 ( +0.63% ) 139.7K

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

Market Data


Open


$1.60

Previous close


$1.59

Volume


139.7K

Market cap


$105.40M

Day range


$1.56 - $1.64

52 week range


$1.08 - $3.79

Insider Ownership Transactions

Total Amount Purchased: -493,016.00 | $ -788,825.60

Date Type Amount Purchased Purchaser
2024-05-17 Sale -30000.00 Witz Pascale
2024-03-15 Sale -250000.00 PAPADOPOULOS STELIOS
2024-01-18 Sale -5468.00 CALSADA CRISPINA
2024-01-18 Sale -5468.00 Aker Christopher Ray
2024-01-18 Sale -14580.00 Hagan Joseph P
2024-01-17 Sale -120000.00 Klassen Preston
2024-01-17 Sale -30000.00 Hagan Joseph P
2024-01-17 Sale -11250.00 CALSADA CRISPINA
2024-01-17 Sale -11250.00 Aker Christopher Ray
2023-08-14 Sale -15000.00 PAPADOPOULOS STELIOS

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
10-q Quarterly Reports 52 May 09, 2024
8-k 8K-related 15 May 09, 2024
def Proxies and info statements 18 Apr 19, 2024
ars Annual reports 1 Apr 19, 2024
10-k Annual reports 88 Mar 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.